A detailed history of Sei Investments CO transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 12,399 shares of CCCC stock, worth $30,129. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,399
Holding current value
$30,129
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$3.6 - $7.0 $44,636 - $86,793
12,399 New
12,399 $44,000
Q2 2023

Aug 11, 2023

SELL
$2.75 - $3.77 $2,642 - $3,622
-961 Reduced 7.91%
11,191 $30,000
Q1 2023

May 12, 2023

BUY
$3.1 - $9.02 $2,842 - $8,271
917 Added 8.16%
12,152 $38,000
Q4 2022

Feb 10, 2023

SELL
$5.42 - $10.24 $1,983 - $3,747
-366 Reduced 3.15%
11,235 $66,000
Q3 2022

Nov 14, 2022

BUY
$8.03 - $12.77 $93,156 - $148,144
11,601 New
11,601 $102,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $119M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.